|Bid||65.00 x 2200|
|Ask||65.00 x 1000|
|Day's range||64.24 - 65.25|
|52-week range||56.56 - 85.79|
|Beta (5Y monthly)||0.41|
|PE ratio (TTM)||664.39|
|Earnings date||28 Apr 2021 - 03 May 2021|
|Forward dividend & yield||2.84 (4.36%)|
|Ex-dividend date||12 Mar 2021|
|1y target est||74.85|
Dr. Shereef Elnahal, University Hospital CEO, Former NJDOH Commissioner, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on coronavirus vaccines.
Tejaswini Mishra, PhD, Research Scientist in the Department of Genetics at Stanford University School of Medicine, joins Yahoo Finance’s Alexis Christoforous to discuss the use of wearables to detect COVID-19.
Gilead (GILD) obtains full approval for its breast cancer drug, Trodelvy, in the United States for metastatic triple-negative breast cancer.